Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
794.90
687.50
572.60
627.70
622.10
590.20
515.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
794.90
687.50
572.60
627.70
622.10
590.20
515.30
Raw Material Cost
14.00
11.30
9.20
15.50
13.60
15.60
12.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
49.70
80.20
Selling and Distribution Expenses
291.60
286.30
276.50
287.80
234.30
242.00
243.10
Other Expenses
25.00
24.43
26.32
17.94
18.94
13.50
7.39
Total Expenditure (Excl Depreciation)
555.60
541.90
548.90
482.70
437.30
442.30
410.00
Operating Profit (PBDIT) excl Other Income
239.3
145.6
23.700000000000003
145
184.8
147.89999999999998
105.3
Other Income
22.20
20.60
21.70
22.50
23.40
22.80
23.40
Operating Profit (PBDIT)
269.20
173.50
53.00
174.60
214.70
178.00
134.90
Interest
0.00
0.00
0.00
0.00
0.00
49.70
80.20
Exceptional Items
30.30
-6.70
-30.70
-4.90
-17.90
-22.40
-14.00
Gross Profit (PBDT)
780.90
676.20
563.40
612.20
608.50
574.60
502.50
Depreciation
7.70
7.30
7.60
7.10
6.50
7.30
6.20
Profit Before Tax
291.80
159.50
14.70
162.60
190.30
98.60
34.50
Tax
82.30
52.00
6.80
59.50
60.50
33.60
-8.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
209.50
107.50
7.90
103.10
129.80
65.00
43.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
209.50
107.50
7.90
103.10
129.80
65.00
43.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
209.50
107.50
7.90
103.10
129.80
65.00
43.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
3,003.60
2,694.30
2,535.70
2,589.70
2,718.90
2,509.20
2,386.10
Earnings per share (EPS)
2.04
1.06
0.08
1.0
1.24
0.63
0.42
Diluted Earnings per share
2.04
1.06
0.08
1.0
1.24
0.63
0.42
Operating Profit Margin (Excl OI)
30.1%
21.18%
4.14%
23.1%
29.71%
25.06%
20.43%
Gross Profit Margin
37.68%
24.26%
3.89%
27.04%
31.63%
17.94%
7.9%
PAT Margin
26.36%
15.64%
1.38%
16.43%
20.86%
11.01%
8.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 27.78% vs 24.72% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 61.40% vs 56.20% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 29.12% vs 30.40% in Sep 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Neurocrine Biosciences, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
794.90
399.36
395.54
99.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
794.90
399.36
395.54
99.04%
Raw Material Cost
14.00
169.22
-155.22
-91.73%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
24.44
-24.44
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
7.57
-7.57
-100.00%
Selling and Distribution Expenses
291.60
74.12
217.48
293.42%
Other Expenses
25.00
18.69
6.31
33.76%
Total Expenditure (Excl Depreciation)
555.60
462.24
93.36
20.20%
Operating Profit (PBDIT) excl Other Income
239.30
-62.88
302.18
480.57%
Other Income
22.20
7.68
14.52
189.06%
Operating Profit (PBDIT)
269.20
-33.38
302.58
906.47%
Interest
0.00
7.57
-7.57
-100.00%
Exceptional Items
30.30
-131.28
161.58
123.08%
Gross Profit (PBDT)
780.90
230.13
550.77
239.33%
Depreciation
7.70
21.82
-14.12
-64.71%
Profit Before Tax
291.80
-194.05
485.85
250.37%
Tax
82.30
-14.10
96.40
683.69%
Provisions and contingencies
0
0
0.00
Profit After Tax
209.50
-179.95
389.45
216.42%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
209.50
-179.95
389.45
216.42%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
209.50
-179.95
389.45
216.42%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
3,003.60
1,320.12
1,683.48
127.52%
Earnings per share (EPS)
2.04
-1.80
3.84
213.33%
Diluted Earnings per share
2.04
-1.80
3.84
213.33%
Operating Profit Margin (Excl OI)
30.10%
-15.75%
0.00
45.85%
Gross Profit Margin
37.68%
-43.13%
0.00
80.81%
PAT Margin
26.36%
-45.06%
0.00
71.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 79.49 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 15.62% vs 20.07% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 27.78% vs 24.72% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.95 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 94.88% vs 1,260.76% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 61.40% vs 56.20% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.70 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 61.54% vs 388.50% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 29.12% vs 30.40% in Sep 2024
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.10%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
